Medpage Today, January 11, 2018

An FDA advisory committee voted 13-6 today against recommending the approval of the oral testosterone undecanoate capsule Tlando (Lipocine) for the treatment of hypogonadism in adult males.

Facebook icon
LinkedIn icon
Twitter icon